(AKE) Arkema - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0010313833
AKE: Adhesives, Coatings, Polymers, Resins, Additives, Chemicals
Arkema S.A. (PA:AKE) is a global leader in the production of specialty chemicals and advanced materials, operating across three distinct business segments. The companys product portfolio is deeply integrated into various industries, making it a critical player in both established and emerging markets.
The Adhesive Solutions segment is a cornerstone of Arkemas business, delivering innovative bonding technologies for construction, automotive, and packaging industries. This division is also a major supplier of high-performance polymers, including specialty polyamides and fluoropolymers, which are essential for applications requiring extreme durability and resistance.
The Advanced Materials and Coating Solutions segment is at the forefront of Arkemas innovation, catering to high-growth sectors like electronics, 3D printing, and water treatment. This division develops cutting-edge coating resins and additives that enhance performance and sustainability in industrial and consumer applications.
The Intermediates segment provides critical chemical building blocks used in the production of fluoropolymers, acrylics, and other industrial chemicals. These materials are vital for industries ranging from construction and automotive to energy and electronics.
From a financial perspective, Arkema S.A. currently has a market capitalization of 5,826.90M EUR, with a trailing P/E ratio of 16.70 and a forward P/E of 7.76. The companys price-to-book ratio stands at 0.81, and its price-to-sales ratio is 0.61. These metrics provide insight into the companys valuation and potential for future growth.
Headquartered in Colombes, France, Arkema S.A. has established itself as a key innovator in the chemicals industry, with a strong focus on sustainability and advanced materials. For more information, visit their website at https://www.arkema.com.
Additional Sources for AKE Stock
AKE Stock Overview
Market Cap in USD | 5,691m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Diversified Chemicals |
IPO / Inception |
AKE Stock Ratings
Growth Rating | -20.4 |
Fundamental | -0.39 |
Dividend Rating | 92.7 |
Rel. Strength | -29.3 |
Analysts | - |
Fair Price Momentum | 61.05 EUR |
Fair Price DCF | 99.41 EUR |
AKE Dividends
Dividend Yield 12m | 9.99% |
Yield on Cost 5y | 11.10% |
Annual Growth 5y | 9.73% |
Payout Consistency | 97.2% |
AKE Growth Ratios
Growth Correlation 3m | -48.6% |
Growth Correlation 12m | -74.4% |
Growth Correlation 5y | -10.4% |
CAGR 5y | -0.82% |
CAGR/Max DD 5y | -0.02 |
Sharpe Ratio 12m | -0.66 |
Alpha | -38.44 |
Beta | 0.589 |
Volatility | 47.28% |
Current Volume | 0k |
Average Volume 20d | 235.9k |
As of April 19, 2025, the stock is trading at EUR 61.35 with a total of 0 shares traded.
Over the past week, the price has changed by +2.34%, over one month by -26.08%, over three months by -17.71% and over the past year by -34.66%.
Neither. Based on ValueRay Fundamental Analyses, Arkema is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -0.39 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AKE as of April 2025 is 61.05. This means that AKE is currently overvalued and has a potential downside of -0.49%.
Arkema has no consensus analysts rating.
According to ValueRays Forecast Model, AKE Arkema will be worth about 65.9 in April 2026. The stock is currently trading at 61.35. This means that the stock has a potential upside of +7.47%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 100 | 63% |
Analysts Target Price | - | - |
ValueRay Target Price | 65.9 | 7.5% |